Los Angeles Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$735K Buy
7,388
+7,354
+21,629% +$740K ﹤0.01% 815
2026
Q1
$3.01K Hold
34
– – ﹤0.01% 2236
2025
Q4
$2.58K Buy
+34
New +$2.59K ﹤0.01% 2401
2025
Q3
– Sell
-2,504
Closed -$236K – 1467
2025
Q2
$236K Sell
2,504
-520
-17% -$57.1K ﹤0.01% 1132
2025
Q1
$359K Sell
3,024
-370
-11% -$50.4K ﹤0.01% 843
2024
Q4
$448K Buy
3,394
+100
+3% +$12.3K ﹤0.01% 838
2024
Q3
$428K Sell
3,294
-2,219
-40% -$261K ﹤0.01% 905
2024
Q2
$478K Hold
5,513
– – ﹤0.01% 869
2024
Q1
$605K Buy
+5,513
New +$555K ﹤0.01% 819

Other funds holding MLAB

Los Angeles Capital Management's MLAB Position: Q2 2026 in Review

Los Angeles Capital Management increased its Mesa Laboratories (MLAB) stake by 21,629% in Q2 2026, buying an estimated $740K and bringing the position to 7,388 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Los Angeles Capital Management first reported a position in MLAB in Q1 2024 and has held it in 9 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Los Angeles Capital Management held 7,388 shares of Mesa Laboratories worth $735K as of Q2 2026.
  • Los Angeles Capital Management bought 7,354 Mesa Laboratories shares in Q2 2026, an estimated $740K.
  • Mesa Laboratories made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #815 holding.
  • Los Angeles Capital Management first reported a position in Mesa Laboratories in Q1 2024 and has held it in 9 quarters since.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.